Hybrid near-infrared-activated luminescent gold nanoparticle platform for efficient cancer therapy
Source abstract
Abstract
Abstract The development of a multifunctional therapy nanoplatform is of crucial importance to tackle the complex challenges associated with cancer. Despite significant advancements in tumor treatment, the efficacy of these traditional approaches remains insufficient. Recurrence and metastasis following tumor treatment continue to represent a significant contributor to tumor-related mortality. This paper presents an improved, facile, and relatively green fabrication of (5-mercapto-1,3,4-thiadiazol-2-ylthio) acetic acid (TMT)-coated luminescent gold nanoparticles (L-AuNP@TMT), which exhibit highly membrane-targeting capacity and superior photodynamic properties. Furthermore, in vivo tumor-bearing mouse model experiments indicated that the L-AuNP@TMT could be used as a two-photon excited nanomedicine via pyroptosis-mediated anti-tumor immunity for effectively eliminating colorectal cancer (CRC), the third most common malignancy and the second deadliest cancer, without evident toxic side effects or tumor metastasis/recurrence. According to its facile and green fabrication approach, near-infrared light-activatable highly efficient photodynamic cancer therapy, and noninvasive imaging mode, this multifunctional nanoplatform offers significant advantages over traditional monotherapy techniques, providing an alternative for the precise clinical treatment of cancer.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Hydrogen's biological and therapeutic effects · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (74)
Show source-provided references
1. Molinari C, Marisi G, Passardi A et al (2018) Heterogeneity in colorectal cancer: a challenge for personalized medicine? Int J Mol Sci 19(12):373310.3390/ijms19123733 ↗
2. Xi Y, Xu P (2021) Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 14(10):10117410.1016/j.tranon.2021.101174 ↗
3. Santucci C, Boffetta P, Levi F et al (2021) Colorectal cancer mortality in young adults is rising in the United States, Canada, United Kingdom, and Australia but not in Europe and Asia. Gastroenterology 160(5):1860–186210.1053/j.gastro.2020.12.070 ↗
4. Cheng E, Blackburn HN, Ng K et al (2021) Analysis of survival among adults with early-onset colorectal cancer in the National Cancer Database. JAMA Netw Open 4(6):e211253910.1001/jamanetworkopen.2021.12539 ↗
5. Golshani G, Zhang Y (2020) Advances in immunotherapy for colorectal cancer: a review. Therap Adv Gastroenterol 13:175628482091752710.1177/1756284820917527 ↗
6. Goodwin RA, Asmis TR (2009) Overview of systemic therapy for colorectal cancer. Clin Colon Rectal Surg 22(4):251–25610.1055/s-0029-1242465 ↗
7. Cronin KA, Lake AJ, Scott S et al (2018) Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer 124(13):2785–280010.1002/cncr.31551 ↗
8. Bhargava D, Rattanadecho P, Jiamjiroch K (2024) Microwave imaging for breast cancer detection-a comprehensive review. Eng Sci 30:1116
9. Sudhi M, Shukla VK, Shetty DK et al (2023) Advancements in bladder cancer management: a comprehensive review of artificial intelligence and machine learning applications. Eng Sci 26(2):1003
10. Preechaphonkul W, Rattanadecho P (2022) The effects of dielectric & thermal property functions on the thermal response during the focused microwave ablation treatment in the liver cancer model: numerical investigation. Eng Sci 21:788
11. Sharma D, Kudva V, Patil V et al (2022) A convolutional neural network based deep learning algorithm for identification of oral precancerous and cancerous lesion and differentiation from normal mucosa: a retrospective study. Eng Sci 18:278–287
12. Fukumura D, Kloepper J, Amoozgar Z et al (2018) Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol 15(5):325–34010.1038/nrclinonc.2018.29 ↗
13. Canale FP, Basso C, Antonini G et al (2021) Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature 598(7882):662–66610.1038/s41586-021-04003-2 ↗
14. Malik U, Pal D (2023) Cancer-fighting isoxazole compounds: sourcing nature’s potential and synthetic advancements-a comprehensive review. ESFAF 15:1052
15. Abdjan MI, Rosyda M, Aminah NS (2023) Synthesis of ester derivatives of catechin isolated from Uncaria gambir and their anticancer activity. Eng Sci 27:997
16. Parida SK, Banerjee P, Biswas D (2023) Enumeration of aeromycoflora diversity in the central library of Kalinga University. ESFAF 14:966
17. Mondal SK, Perumal V, Das R et al (2022) Antimicrobial and anticancer activity of a novel peptide (musterolysin) extracted from slurry of mustard oil refinery industry. ESFAF 10:24–29
18. Liu Y, Murugadoss V, Cui B et al (2021) Synthesis of Janus Fe3O4&mSiO2 nanocarriers for chemo-microwave therapy of cancer cells. ESEE 14:43–53
19. Hiam-Galvez KJ, Allen BM, Spitzer MH (2021) Systemic immunity in cancer. Nat Rev Cancer 21(6):345–35910.1038/s41568-021-00347-z ↗
20. Upadhyay R, Boiarsky JA, Pantsulaia G et al (2021) A critical role for Fas-mediated off-target tumor killing in T-cell immunotherapy. Cancer Discov 11(3):599–61310.1158/2159-8290.CD-20-0756 ↗
21. D’Souza CA, Heitman J (2001) Dismantling the Cryptococcus coat. Trends Microbiol 9(3):112–11310.1016/S0966-842X(00)01945-4 ↗
22. Jiang M, Qi L, Li L et al (2020) The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov 6(1):11210.1038/s41420-020-00349-0 ↗
23. Wang Y, Gao W, Shi X et al (2017) Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547(7661):99–10310.1038/nature22393 ↗
24. Wu D, Wang S, Yu G et al (2021) Cell death mediated by the pyroptosis pathway with the aid of nanotechnology: prospects for cancer therapy. Angew Chem Int Ed Engl 60(15):8018–803410.1002/anie.202010281 ↗
25. Li L, Song D, Qi L et al (2021) Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis. Cancer Lett 520:143–15910.1016/j.canlet.2021.07.014 ↗
26. Meng Z, Zhou X, Xu J et al (2019) Light-triggered in situ gelation to enable robust photodynamic-immunotherapy by repeated stimulations. Adv Mater 31(24):190092710.1002/adma.201900927 ↗
27. Li Z, Lai X, Fu S et al (2022) Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency. Adv Sci 9(22):220173410.1002/advs.202201734 ↗
28. Li J, Ou H, Ding D (2021) Recent progress in boosted PDT induced immunogenic cell death for tumor immunotherapy. Chem Res Chin Univ 37(1):83–8910.1007/s40242-021-0402-5 ↗
29. Liu R, Wang R, Zhao M et al (2023) Ultra-small radiosensitizers deliver epigenetic drugs to induce pyroptosis and boost triple-negative breast cancer radiotherapy. Nano Today 52:10199710.1016/j.nantod.2023.101997 ↗
30. Wu B, Wang M, Sun Y et al (2022) Near-infrared chirality of plasmonic metasurfaces with gold rectangular holes. Adv Compos Hybrid Mater 5(3):2527–253510.1007/s42114-022-00513-3 ↗
31. Yuan M, Feng X, Yan TH et al (2022) Superparamagnetic iron oxide-enclosed hollow gold nanostructure with tunable surface plasmon resonances to promote near-infrared photothermal conversion. Adv Compos Hybrid Mater 5(3):2387–239810.1007/s42114-022-00444-z ↗
32. Zhu S, Yan F, Yang L et al (2023) Low-dose X-ray radiodynamic therapy solely based on gold nanoclusters for efficient treatment of deep hypoxic solid tumors combined with enhanced antitumor immune response. Theranostics 13(3):1042–105810.7150/thno.78649 ↗
33. Han R, Zhao M, Wang Z et al (2020) Super-efficient in vivo two-photon photodynamic therapy with a gold nanocluster as a type I photosensitizer. ACS Nano 14(8):9532–954410.1021/acsnano.9b05169 ↗
34. Yang L, Yan F, Zhu S et al (2024) Highly luminescent gold nanoparticles prepared via a facile photochemical method for bioimaging applications. Adv Compos Hybrid Mater 7(5):15210.1007/s42114-024-00964-w ↗
35. Chen WH, Luo GF, Zhang XZ (2019) Recent advances in subcellular targeted cancer therapy based on functional materials. Adv Mater 31(3):180272510.1002/adma.201802725 ↗
36. Snyder JW, Skovsen E, Lambert JD et al (2005) Subcellular, time-resolved studies of singlet oxygen in single cells. J Am Chem Soc 127(42):14558–1455910.1021/ja055342p ↗
37. Skovsen E, Snyder JW, Lambert JD et al (2005) Lifetime and diffusion of singlet oxygen in a cell. J Phys Chem B 109(18):8570–857310.1021/jp051163i ↗
38. Wang H, Jing G, Niu J et al (2022) A mitochondria-anchored supramolecular photosensitizer as a pyroptosis inducer for potent photodynamic therapy and enhanced antitumor immunity. J Nanobiotechnology 20(1):51310.1186/s12951-022-01719-9 ↗
39. Wu M, Liu X, Chen H et al (2021) Activation of pyroptosis by membrane-anchoring AIE photosensitizer design: new prospect for photodynamic cancer cell ablation. Angew Chem Int Ed Engl 60(16):9093–909810.1002/anie.202016399 ↗
40. Hu ZC, Wang B, Zhou XG et al (2023) Golgi apparatus-targeted photodynamic therapy for enhancing tumor immunogenicity by eliciting NLRP3 protein-dependent pyroptosis. ACS Nano 17(21):21153–2116910.1021/acsnano.3c05005 ↗
41. Duan X, Chan C, Guo N et al (2016) Photodynamic therapy mediated by nontoxic core-shell nanoparticles synergizes with immune checkpoint blockade to elicit antitumor immunity and antimetastatic effect on breast cancer. J Am Chem Soc 138(51):16686–1669510.1021/jacs.6b09538 ↗
42. Dai Z, Tang J, Gu Z et al (2020) Eliciting immunogenic cell death via a unitized nanoinducer. Nano Lett 20(9):6246–625410.1021/acs.nanolett.0c00713 ↗
43. Lu Y, Sun W, Du J et al (2023) Immuno-photodynamic therapy (IPDT): organic photosensitizers and their application in cancer ablation. JACS Au 3(3):682–69910.1021/jacsau.2c00591 ↗
44. Shen L, Zhou T, Fan Y et al (2020) Recent progress in tumor photodynamic immunotherapy. Chin Chem Lett 31(7):1709–171610.1016/j.cclet.2020.02.007 ↗
45. Wei X, Song M, Jiang G et al (2022) Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor. Theranostics 12(12):5272–529810.7150/thno.73566 ↗
46. Yang G, Pan X, Feng W et al (2023) Engineering Au44 nanoclusters for NIR-II luminescence imaging-guided photoactivatable cancer immunotherapy. ACS Nano 17(16):15605–1561410.1021/acsnano.3c02370 ↗
47. Zhang W, Liu Z, Zhu J et al (2023) Bioorthogonal disruption of pyroptosis checkpoint for high-efficiency pyroptosis cancer therapy. J Am Chem Soc 145(30):16658–1666810.1021/jacs.3c04180 ↗
48. Zhang L, Wan SC, Zhang J et al (2023) Activation of pyroptosis using AIEgen-based sp2 carbon-linked covalent organic frameworks. J Am Chem Soc 145(32):17689–1769910.1021/jacs.3c04027 ↗
49. Dong Y, Arif AA, Poon GF et al (2016) Generation and identification of GM-CSF derived alveolar-like macrophages and dendritic cells from mouse bone marrow. J Vis Exp 25(112):54194
50. Link S, Beeby A, FitzGerald S et al (2002) Visible to infrared luminescence from a 28-atom gold cluster. J Phys Chem B 106(13):3410–341510.1021/jp014259v ↗
51. Xu D, Wu L, Yao H et al (2022) Catalase-like nanozymes: classification, catalytic mechanisms, and their applications. Small 18(37):220340010.1002/smll.202203400 ↗
52. Yang M, Tahara ZM, Y, et al (2014) Lysosomal membrane permeabilization: carbon nanohorn-induced reactive oxygen species generation and toxicity by this neglected mechanism. Toxicol Appl Pharmacol 280(1):117–12610.1016/j.taap.2014.07.022 ↗
53. Liu X, Liu Y, Li X et al (2022) ER-targeting PDT converts tumors into in situ therapeutic tumor vaccines. ACS Nano 16(6):9240–925310.1021/acsnano.2c01669 ↗
54. Terman A, Kurz T, Gustafsson B et al (2006) Lysosomal labilization. IUBMB life 58(9): 531-53910.1080/15216540600904885 ↗
55. Kurz T, Terman A, Gustafsson B et al (2008) Lysosomes and oxidative stress in aging and apoptosis. Biochim Biophys Acta 1780(11):1291–130310.1016/j.bbagen.2008.01.009 ↗
56. Leist M, Jäättelä M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2(8):589–59810.1038/35085008 ↗
57. Boya P, Andreau K, Poncet D et al (2003) Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 197(10):1323–133410.1084/jem.20021952 ↗
58. Zhao M, Antunes F, Eaton JW et al (2003) Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. Eur J Biochem 270(18):3778–378610.1046/j.1432-1033.2003.03765.x ↗
59. Erdal H, Berndtsson M, Castro J et al (2005) Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 102(1):192–19710.1073/pnas.0408592102 ↗
60. Bhandary M, Sales Conniff A, Miranda K et al (2022) Acute effects of intratumor DNA electrotransfer. Pharmaceutics 14(10):209710.3390/pharmaceutics14102097 ↗
61. Wan X, Li J, Wang Y et al (2022) H7N9 virus infection triggers lethal cytokine storm by activating gasdermin E-mediated pyroptosis of lung alveolar epithelial cells. Natl Sci Rev 9(1):nwab13710.1093/nsr/nwab137 ↗
62. Jiang M, Qi L, Li L et al (2020) The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Dis 6:11210.1038/s41420-020-00349-0 ↗
63. Zhang Z, Zhang H, Li D et al (2021) Caspase-3-mediated GSDME induced pyroptosis in breast cancer cells through the ROS/JNK signalling pathway. J Cell Mol Med 25(17):8159–816810.1111/jcmm.16574 ↗
64. Hu Y, Liu Y, Zong L et al (2023) The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles. Cell Death Dis 14(12):83610.1038/s41419-023-06382-y ↗
65. Burdette BE, Esparza AN, Zhu H et al (2021) Gasdermin D in pyroptosis. Acta Pharm Sin B 11(9):2768–278210.1016/j.apsb.2021.02.006 ↗
66. Murao A, Aziz M, Wang H et al (2021) Release mechanisms of major DAMPs. Apoptosis 26(3):152–16210.1007/s10495-021-01663-3 ↗
67. Yao F, Zheng Z, Lv X et al (2022) HDAC11 promotes both NLRP3/caspase-1/GSDMD and caspase-3/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells. Cell Death Dis 8(1):11210.1038/s41420-022-00906-9 ↗
68. Chen C, Cheng Y, Lei H et al (2023) SHP2 potentiates anti-PD-1 effectiveness through intervening cell pyroptosis resistance in triple-negative breast cancer. Biomed Pharmacother 168:11579710.1016/j.biopha.2023.115797 ↗
69. Hung SI, Chu MT, Hou MM et al (2023) Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer. Biomed Pharmacother 169:11592810.1016/j.biopha.2023.115928 ↗
70. Conejo-Garcia JR, Biswas S, Chaurio R et al (2023) Neglected no more: B cell-mediated anti-tumor immunity. Semin Immunol 65:10170710.1016/j.smim.2022.101707 ↗
71. Bonilla FA, Oettgen HC (2010) Adaptive immunity. J Allergy Clin Immunol 125(2 Suppl 2):33–4010.1016/j.jaci.2009.09.017 ↗
72. Adam R, Vinet E (2004) Regional treatment of metastasis: surgery of colorectal liver metastases. Ann Oncol 15(Suppl 4):103–10610.1093/annonc/mdh912 ↗
73. Adhikari B, Banerjee A (2010) Facile synthesis of water-soluble fluorescent silver nanoclusters and HgII sensing. Chem Mater 22(15):4364–437110.1021/cm1001253 ↗
74. Zhou C, Long M, Qin Y et al (2011) Luminescent gold nanoparticles with efficient renal clearance. Angew Chem Int Ed Engl 50(14):3168–317210.1002/anie.201007321 ↗